Drugs / Netupitant/Palonosetron Hydrochloride
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03367572 Background | Apr 2018 → Apr 2024 | breast carcinoma | University of Rochester NCORP Research Base | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Netupitant/Palonosetron Hydrochloride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03367572 ↗ |
| Route | Oral | “Given PO” NCT03367572 ↗ |